Other complications associated with artificial fertilization. Noninflammatory disorders of female genital tract
Conditions
Interventions
Intervention 1: Intervention: Duphaston(Oral Didrogesterone 10mg) 20mg , Twice daily until 12 weeks. Intervention 2: Intervention: Vaginal progesterone( Cyclogest 400 microgram) Daily until 12 weeks.
Treatment - Drugs
Intervention: Duphaston(Oral Didrogesterone 10mg) 20mg , Twice daily until 12 weeks.
Intervention: Vaginal progesterone( Cyclogest 400 microgram) Daily until 12 weeks
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Science
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria; Women younger than 35 years old with unexplained infertility; Proper ovulation; 2 open tubal; Not having severe or moderate problem of man and without a history of previous abdominal surgery. Exclusion criteria; Advanced endometriosis; Dense pelvic adhesion; Genital TB; Patients who did not reffer for following up.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical pregnancy rate. Timepoint: two weeks after start of intervention. Method of measurement: Transvaginal ultrasonography and pregnancy test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Miscariage rate. Timepoint: Until 24 weeks after start of intervention. Method of measurement: History, Physical exam, Ultrasonography.;Patients acceptance. Timepoint: Untill 12 weeks. Method of measurement: Questionare.;Progestrone serum level. Timepoint: one week after start of intervention. Method of measurement: measure of blood progestrone. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactrobabeh taheripanah
Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science
Outcome results
None listed